Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Maughan, Timothy S, Prof ; Adams, Richard A, FRCP ; Smith, Christopher G, BSc ; Meade, Angela M, DPhil ; Seymour, Matthew T, Prof ; Wilson, Richard H, MD ; Idziaszczyk, Shelley, MPhil ; Harris, Rebecca, MSc ; Fisher, David, MSc ; Kenny, Sarah L, MSc ; Kay, Edward, BA ; Mitchell, Jenna K, BHSc ; Madi, Ayman, MRCP ; Jasani, Bharat, Prof ; James, Michelle D, BSc ; Bridgewater, John, MD ; Kennedy, M John, MD ; Claes, Bart, MSc ; Lambrechts, Diether, PhD ; Kaplan, Richard, Prof ; Cheadle, Jeremy P, Prof

The Lancet (British edition), 2011-06, Vol.377 (9783), p.2103-2114 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível